Otsuka Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTSKY research report →
Price Chart
About the company
Otsuka Holdings Co. , Ltd. engages in the management of its group companies which are in the pharmaceuticals business.
- CEO
- Makoto Inoue
- IPO
- 2012
- Employees
- 37,758
- HQ
- Tokyo, TY, JP
Get TickerSpark's AI analysis on OTSKY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $41.39B
- P/E
- 16.40
- Fwd P/E
- 0.12
- PEG
- 20.46
- P/S
- 2.53
- P/B
- 2.05
- EV/EBITDA
- 9.98
- Div Yield
- 1.35%
- Gross Margin
- 71.78%
- Op Margin
- 17.26%
- Net Margin
- 15.46%
- ROE
- 13.24%
- ROIC
- 9.52%
Latest fiscal year · YoY change
- Revenue
- $2.59T+11.1%
- Gross Profit
- $1.86T+11.2%
- Op Income
- $432.43B
- Net Income
- $380.76B+11.0%
- EPS
- $359.19+13.4%
- OCF Growth
- +19.3%
- FCF Growth
- +47.0%
- 52W High
- $40.92
- 52W Low
- $25.30
- 50D MA
- $35.04
- 200D MA
- $32.61
- Beta
- -0.05
- RSI (14)
- 62
- Avg Volume
- 42.87K
No earnings-call transcripts are available for OTSKY yet.
- Free Float
- 41.9%
- Shares Outstanding
- 1.05B
- Float Shares
- 440.72M
of shares held by institutions
10 13F filers
Congressional trading
Senate and House stock disclosures for OTSKY, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| First Horizon Advisors, Inc. | 394 | ▲ 374 |
Held by 3 ETFs
Biggest fund positions in OTSKY by dollar value.
Our OTSKY coverage
Recent articles, reports, and earnings notes.
No research on OTSKY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTSKY report →Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
seekingalpha.com · Aug 6
Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Aug 5
Aristotle Global Equity Advisory Q2 2026 Portfolio Review
seekingalpha.com · Jul 30
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
prnewswire.com · Jul 9
AstraZeneca (OTCMKTS:AZNCF) versus Otsuka (OTCMKTS:OTSKY) Financial Review
defenseworld.net · Apr 17
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
seekingalpha.com · Apr 10
Santen Pharmaceutical (OTCMKTS:SNPHY) & Otsuka (OTCMKTS:OTSKY) Financial Review
defenseworld.net · Mar 23
Contrasting Otsuka (OTCMKTS:OTSKY) and Mayne Pharma Group (OTCMKTS:MAYNF)
defenseworld.net · Mar 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.